Reactive oxygen species and matrix remodeling in diabetic kidney.
about
Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequencesReactive oxygen species and fibrosis: further evidence of a significant liaisonOxidative stress and glutathione in TGF-beta-mediated fibrogenesisA potential role for caveolin-1 in VEGF-induced fibronectin upregulation in mesangial cells: involvement of VEGFR2 and SrcFluvastatin inhibits activation of JAK and STAT proteins in diabetic rat glomeruli and mesangial cells under high glucose conditionsAirway smooth muscle relaxation is impaired in mice lacking the p47phox subunit of NAD(P)H oxidaseKidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathyRationale for combining a direct renin inhibitor with other renin- angiotensin system blockers. Focus on aliskiren and combinations.Dedifferentiation of immortalized human podocytes in response to transforming growth factor-β: a model for diabetic podocytopathy.High glucose stimulates TNFα and MCP-1 expression in rat microglia via ROS and NF-κB pathways.Resveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro.Dimethylfumarate attenuates renal fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signalingThe Impact of Overnutrition on Insulin Metabolic Signaling in the Heart and the KidneyRole of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathyEffect of 5/6 nephrectomized rat serum on epithelial-to-mesenchymal transition in vitroHeparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells.Clusterin attenuates the development of renal fibrosis.Activation of AMP-activated protein kinase prevents TGF-β1-induced epithelial-mesenchymal transition and myofibroblast activation.Epithelial-mesenchymal transition in lung cancer: is tobacco the "smoking gun"?Intrarenal oxygenation in chronic renal failure.KCa3.1 mediates dysfunction of tubular autophagy in diabetic kidneys via PI3k/Akt/mTOR signaling pathwaysOxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts.The role of tubular epithelial-mesenchymal transition in progressive kidney disease.Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9.Increased superoxide levels in ganglia and sympathoexcitation are involved in sarafotoxin 6c-induced hypertension.Role of Kruppel-like factor 6 in transforming growth factor-beta1-induced epithelial-mesenchymal transition of proximal tubule cellsThioredoxin interacting protein (TXNIP) regulates tubular autophagy and mitophagy in diabetic nephropathy through the mTOR signaling pathway.Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice.The orphan nuclear receptor SHP attenuates renal fibrosis.New insights into hyperglycemia-induced molecular changes in microvascular cells.The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology.NADPH oxidase and cardiac failure.Regulation of myocardial growth and death by NADPH oxidase.Cell signaling and receptors in toxicity of advanced glycation end products (AGEs): α-dicarbonyls, radicals, oxidative stress and antioxidants.High Glucose-Induced Hypomethylation Promotes Binding of Sp-1 to Myo-Inositol Oxygenase: Implication in the Pathobiology of Diabetic Tubulopathy.Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase.Effect of cilostazol in treating diabetes-associated microvascular complications.A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FGF-2-induced renal epithelial-mesenchymal transition.Hyperglycemia induced damage to mitochondrial respiration in renal mesangial and tubular cells: Implications for diabetic nephropathy.Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.
P2860
Q26786129-947D46C7-3B02-4793-AF86-52B0CD4F9987Q28077930-0EADF47E-60A4-4FC0-AF77-F4C35764F8B3Q28393454-F996A4A6-0BD9-4698-B03A-BA2818A68A18Q28567391-0A183B34-29B5-41E4-A546-F02A5C28FC68Q28568345-7C0DC046-B826-4D68-94B7-1D56D7A63E7EQ28588703-A87EB37C-F6C5-4A97-AA74-EF87C6FD5933Q28592666-8780D67F-5372-4938-86F2-E5645C72C07AQ30452640-2A7F2E05-77CF-4481-A9C7-DB2A85C86BC1Q30501075-2480B9C9-928A-4844-B224-67715FB3D0B1Q33565706-DAA471D4-9A69-485E-A731-8A86CC6B4117Q33893097-AAD8FD40-2862-4BF1-A561-5FDDDA3DAAD0Q34441024-E753B85F-59F0-40D7-8030-C2109434A854Q35005356-A84F5327-754A-4BF5-9F41-624A00F8E005Q35035283-A98D9B8F-C95A-434E-927F-36D42460D5F4Q35090003-FEC46F31-8902-4158-9E55-DE54070DD2A2Q35668839-9FC77D91-7A8A-48E5-AD4B-F32BFC11B281Q35720816-1445066F-E130-4E08-8709-DD6D56B84FA7Q35931845-3660DB00-8EEE-4EF9-ABCD-3AE0F614B0B3Q36399326-1C45FA61-6ECE-406F-9055-5E8E532BE542Q36604421-F336C721-6D22-4BC8-9A76-802C360D24F1Q36748426-BD35C4B8-0DC2-4F67-963F-AAE6E09D3202Q36802004-AFF950C2-BE44-41A5-BAED-A34DC3E47806Q36857879-2D3898DD-CF38-4934-B759-B2A525224EFEQ36923702-117606D0-5FF2-4827-A220-F3C8C8CFBC97Q36977226-130D2753-200E-416D-B784-5A49C8E045AAQ36977366-F87963F7-79C0-4519-9949-311D44A403EDQ37067721-200B08C1-BD67-479E-B946-3B8654D5AB8FQ37210162-87AAB98A-6FF1-4190-9B45-5C83037D9E7EQ37367690-B8E1361A-4A8F-48A9-A8FE-31A4442BE822Q37665090-BD7072AE-C723-46A0-A21C-8D6EFFCEF0DEQ37760963-FD38C4C9-E763-4B7D-9F37-270CA08A62FDQ37766127-AEB9973D-7446-4147-927E-7BF8FA3F6C11Q37826870-8704A442-CBD7-47D0-BA61-5C1C21BAB118Q37934954-C4C58847-DE4B-4B9B-9471-FC8ADB1FA4BFQ38716178-09CAA56D-706E-4FE5-B6DA-F96B298CDA75Q39060681-1A2E7FC4-0CF6-46EA-806E-BF1AAC0BB421Q39178804-77F361B8-33CE-48A7-882C-36EF15871C4AQ39254044-CF70B257-3396-4E69-9223-42D9A126A703Q39316856-D28A5551-5A7D-46E2-9EA2-8174F3B86AB9Q41957277-E49BFAA5-64C2-4510-8BBA-DB3FE16EE010
P2860
Reactive oxygen species and matrix remodeling in diabetic kidney.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Reactive oxygen species and matrix remodeling in diabetic kidney.
@ast
Reactive oxygen species and matrix remodeling in diabetic kidney.
@en
type
label
Reactive oxygen species and matrix remodeling in diabetic kidney.
@ast
Reactive oxygen species and matrix remodeling in diabetic kidney.
@en
prefLabel
Reactive oxygen species and matrix remodeling in diabetic kidney.
@ast
Reactive oxygen species and matrix remodeling in diabetic kidney.
@en
P1476
Reactive oxygen species and matrix remodeling in diabetic kidney.
@en
P2093
Hi Bahl Lee
P304
P356
10.1097/01.ASN.0000077411.98742.54
P433
P577
2003-08-01T00:00:00Z